Short answer: I can’t give a definitive yes/no list of “pending patents for nicardipine’s ready-to-use version” because patent status is jurisdiction-specific and changes over time. There isn’t a single global patent status for a “ready-to-use” formulation.
What you should do to get an accurate answer
- Tell me the jurisdiction(s) you care about (e.g., US, EU, UK, Japan, etc.) and the timeframe.
- Clarify what you mean by “ready-to-use version” (e.g., ready-to-use IV injectable solution, pre-mixed parenteral, unit-dose syringe, oral ready-to-use formulation, etc.).
- Note whether you’re investigating freedom-to-operate for manufacturing, or patentability for a product you want to develop.
How to check efficiently
- Patent databases to search:
- Google Patents (patents.google.com) – good first pass; look for families with nicardipine and terms like “ready-to-use,” “pre-mixed,” “intravenous,” “parenteral,” or “formulation.”
- USPTO Patent Center or PatFT (for US status)
- EPO Espacenet (for EU status)
- WIPO Patentscope (PCT filings)
- Search strings to try (in any combination):
- nicardipine AND (ready-to-use OR “ready to use” OR premix OR “pre-mixed”)
- nicardipine AND injection OR parenteral OR intravenous OR IV
- nicardipine AND formulation AND (syringe OR unit-dose OR solution)
- Check “legal status” or “global status” sections in the results to see whether a patent is granted, pending, expired, or lapsed, and in which jurisdictions.
- For marketed products, check the FDA Orange Book for patents and exclusivities associated with nicardipine formulations (e.g., IV or oral products). This can reveal which patents are still listed as protecting a specific product.
- If you’re pursuing a business decision, consider consulting a patent attorney to do a formal freedom-to-operate search and to interpret status across jurisdictions.
If you’d like, tell me:
- The jurisdiction(s) and the exact interpretation of “ready-to-use” you want,
- The time window (e.g., as of today, within the last 5–10 years),
and I can help outline a targeted search plan and summarize any likely active patent families based on the information you provide.